chloroquine has been researched along with osimertinib in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Byun, SY; Choi, I; Jeon, S; Kim, S; Ko, M; Lee, J; Park, S; Shum, D | 1 |
| Liu, H; Yin, W; Zhang, M; Zhang, Z | 1 |
| Feng, M; He, Y; Hu, C; Jiao, L; Li, L; Lin, C; Lu, C; Wang, Y; Wu, H; Ye, J; Zhang, D; Zhang, K | 1 |
3 other study(ies) available for chloroquine and osimertinib
| Article | Year |
|---|---|
Identification of Antiviral Drug Candidates against SARS-CoV-2 from FDA-Approved Drugs.
Topics: Animals; Anti-Inflammatory Agents; Antiviral Agents; Betacoronavirus; Cell Line; Chlorocebus aethiops; Coronavirus Infections; COVID-19; Drug Evaluation, Preclinical; Drug Repositioning; Humans; Niclosamide; Pandemics; Pneumonia, Viral; Pregnenediones; SARS-CoV-2; Vero Cells | 2020 |
AZD9291 promotes autophagy and inhibits PI3K/Akt pathway in NSCLC cancer cells.
Topics: A549 Cells; Acrylamides; Aniline Compounds; Animals; Autophagy; Carcinoma, Non-Small-Cell Lung; Cell Survival; Chloroquine; ErbB Receptors; Gene Knockdown Techniques; Humans; Lung Neoplasms; Mice; Mice, Nude; Microtubule-Associated Proteins; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; RNA-Binding Proteins; Signal Transduction; Transfection; Tumor Burden; Xenograft Model Antitumor Assays | 2019 |
Protective autophagy decreases osimertinib cytotoxicity through regulation of stem cell-like properties in lung cancer.
Topics: Acrylamides; Aldehyde Dehydrogenase 1 Family; Aniline Compounds; Animals; Antineoplastic Agents; Autophagy; Beclin-1; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Chloroquine; Drug Resistance, Neoplasm; ErbB Receptors; Female; Humans; Lung Neoplasms; Mice; Mice, Inbred BALB C; Protein Kinase Inhibitors; Retinal Dehydrogenase; RNA Interference; RNA, Small Interfering; SOXB1 Transcription Factors; Xenograft Model Antitumor Assays | 2019 |